AIP
PRDS

Ameritas Investment Partners’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Ameritas Investment Partners’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,125
Closed -$2.81K – 3275
2023
Q1 		$2.81K Hold
2,125
– – ﹤0.01% 2935
2022
Q4 		$3.95K Hold
2,125
– – ﹤0.01% 2952
2022
Q3 		$3K Hold
2,125
– – ﹤0.01% 2994
2022
Q2 		$6K Buy
+2,125
New +$13K ﹤0.01% 2948

Other funds holding PRDS

FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Ameritas Investment Partners's PRDS Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q2 2023, closing a stake of 2,125 shares — an estimated $2.81K sold.

Ameritas Investment Partners first reported a position in PRDS in Q2 2022 and held it in 4 quarters. The position peaked at $6K in Q2 2022. 59 funds tracked by Wall St. Rank hold PRDS as of Q2 2023.

  • Ameritas Investment Partners reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,125 Pardes Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $2.81K.
  • Ameritas Investment Partners first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Ameritas Investment Partners's Pardes Biosciences, Inc. Common Stock position peaked at $6K in Q2 2022.
  • 59 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.